FDA approves autoinjector option for UCB’s myasthenia gravis drug

Markets Investing.com By Investing.com 16 Oct 2026 11:04 1 min read
FDA approves autoinjector option for UCB’s myasthenia gravis drug

Covered in this story

What has happened since

Price move measured from the close nearest publication to the latest quote.

Call it yourself

No calls on $UCB yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.

Make the first call on United Community Banks Inc →
Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.